Aligos therapeutics appoints kieron wesson as vice president, head of chemistry manufacturing controls (cmc)

South san francisco, calif., june 18, 2025 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of kieron wesson, phd as vice president, head of chemistry manufacturing controls (cmc), effective immediately.
ALGS Ratings Summary
ALGS Quant Ranking